BIVI

BioVie, Inc. Common Stock
Data: 2026-01-30
$1.14
Price
-5.64%
Change
$20.4
52W High
$0.88
52W Low

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Quick Stats
Jan 30, 2026

55.5

AI Score

HOLD

1.39

Volume Ratio

Feb 10, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

BIVI Stock Summary

Last updated Jan 30, 2026

BIVI is currently trading at $1.14, positioned below its 200-day moving average of $3.26, suggesting bearish momentum. The stock has a 52-week range of $0.88 to $20.4.

Technical Analysis: The 50-day moving average stands at $1.34, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.94, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.022, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BIVI at 55.5/100 with a HOLD recommendation.

BIVI (BioVie, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 36.94
CMF (20) 0.022
ROC (10) -3.39
ADX (14) 21.68
Indicator Value
MACD (12,26,9) -0.046
AROONOSC (14) -92.857
WILLAMS %R (14) -90.905
MFI (14) 39.109
BIVI Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BIVI Price vs Max Options Open Interest
BIVI Max Change In Options Open Interest

BIVI Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIVI Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIVI Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BIVI Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

BioVie, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

BIVI Moving Averages Analysis

BIVI (BioVie, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 1.22
20 1.25
30 1.27
50 1.34
100 1.58
200 3.26

BIVI Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 11.2 million
Earnings/Share ($) -12.12
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.02
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) 12
Most Recent Quarter